<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39360101</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Atypical Presentation of Stenotrophomonas maltophilia Stomatitis Post COVID-19 in an Immunocompetent Adolescent.</ArticleTitle><Pagination><StartPage>e68464</StartPage><MedlinePgn>e68464</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68464</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68464</ELocationID><Abstract><AbstractText><i>Stenotrophomonas maltophilia</i> (S. <i>maltophilia</i>) is a rare, multi-drug-resistant opportunistic bacteria that typically causes serious infections in immunocompromised and hospitalized patients, often leading to fatal pneumonia or bacteremia. We present the case of a healthy 15-year-old immunocompetent female who developed severe oral ulcers due to <i>S. maltophilia</i> following a recent COVID-19 infection. To our knowledge, this is the first reported case of <i>S. maltophilia </i>manifesting in this manner after COVID-19. Scrapes from the oral lesions were collected and cultured, confirming the<i> </i>infection.The CBC and immunoglobulin reports revealed mildly elevated IgA and platelet levels, with no evidence of immunodeficiency.The patient was treated with trimethoprim/sulfamethoxazole (TMP-SMX) based on culture sensitivity, and she responded well to treatment. She was referred to an infectious disease specialist for further monitoring. COVID-19 has recently been implicated in many unusual presentations, associations, and syndromes. One of the most supported theories about COVID-19 is its association with a transient immunodeficient state or a generalized state of immune system dysregulation that can compromise both innate and adaptive immunity. This case supports that theory, as no other apparent etiology for such an otherwise opportunistic infection was identified. The recognition of such atypical infections in previously healthy individuals, particularly post COVID-19, highlights the importance of sharpening clinical vigilance and considering opportunistic pathogens in differential diagnoses. Further research is warranted to explore the potential link between COVID-19 and the susceptibility to rare opportunistic infections, which may guide future clinical practices.</AbstractText><CopyrightInformation>Copyright © 2024, Alharami et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alharami</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, Alexandria University School of Medicine, Alexandria, EGY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gastroenterology, Advanced Medical Research Center, Port Orange, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anbar</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of Aleppo School of Medicine, Aleppo, SYR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsharif</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurosurgery, Alfaisal University College of Medicine, Riyadh, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahrawi</LastName><ForeName>Frhaan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, Alexandria University School of Medicine, Alexandria, EGY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemaidan</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gastroenterology, Florida State University College of Medicine, Daytona Beach, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gastroenterology, Advanced Medical Research Center, Port Orange, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">child and adolescent health</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">covid-19-related immune dysregulation</Keyword><Keyword MajorTopicYN="N">immuno-competent</Keyword><Keyword MajorTopicYN="N">opportunistic bacterial infection</Keyword><Keyword MajorTopicYN="N">oral ulcer</Keyword><Keyword MajorTopicYN="N">stenotrophomonas maltophilia infection</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39360101</ArticleId><ArticleId IdType="pmc">PMC11446409</ArticleId><ArticleId IdType="doi">10.7759/cureus.68464</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>UpToDate. Waltham, MA: UpToDate; 2024. Stenotrophomonas maltophilia.</Citation></Reference><Reference><Citation>Said MS, Tirthani E, Lesho E. Treasure Island, FL: StatPearls [Internet], StatPearls Publishing; 2024. Stenotrophomonas maltophilia.</Citation><ArticleIdList><ArticleId IdType="pubmed">34283489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Mahmood SF, Talavera F, Bronze MS, Cunha BA, Levy CS: Stenotrophomonas Maltophilia. Stenotrophomonas maltophilia. 2021. https://emedicine.medscape.com/article/237024-overview?form=fpf https://emedicine.medscape.com/article/237024-overview?form=fpf</Citation></Reference><Reference><Citation>Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Brooke JS. Clin Microbiol Rev. 2012;25:2–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3255966</ArticleId><ArticleId IdType="pubmed">22232370</ArticleId></ArticleIdList></Reference><Reference><Citation>Treatment refractory Stenotrophomonas maltophilia bacteraemia and pneumonia in a COVID-19-positive patient. Pek Z, Cabanilla MG, Ahmed S. BMJ Case Rep. 2021;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212176</ArticleId><ArticleId IdType="pubmed">34140329</ArticleId></ArticleIdList></Reference><Reference><Citation>Co-morbidity of COVID-19 and Stenotrophomonas maltophilia in a patient with Hodgkin’s lymphoma history from north of Iran. Darvishnia D, Sadeghi M, Sharifpour A, Zakariaei Z, Banimostafavi ES, Fakhar M, Tabaripour R. Infect Disord Drug Targets. 2021;21:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538678</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenotrophomonas maltophilia infection associated with COVID-19: a case series and literature review. Ishikawa K, Nakamura T, Kawai F, Uehara Y, Mori N. Am J Case Rep. 2022;23:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308482</ArticleId><ArticleId IdType="pubmed">35852985</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenotrophomonas maltophilia pneumonia in critical COVID-19 patients. Raad M, Abou Haidar M, Ibrahim R, et al. Sci Rep. 2023;13:3392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9971679</ArticleId><ArticleId IdType="pubmed">36854720</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Gajdács M, Urbán E. Health Serv Res Manag Epidemiol. 2019;6:2333392819870774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698998</ArticleId><ArticleId IdType="pubmed">31453265</ArticleId></ArticleIdList></Reference><Reference><Citation>Alterations of the oral microbiome and cumulative carbapenem exposure are associated with Stenotrophomonas maltophilia infection in patients with acute myeloid leukemia receiving chemotherapy. Aitken SL, Sahasrabhojane PV, Kontoyiannis DP, et al. Clin Infect Dis. 2021;72:1507–1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096257</ArticleId><ArticleId IdType="pubmed">32544947</ArticleId></ArticleIdList></Reference><Reference><Citation>StenoSCORE: predicting Stenotrophomonas maltophilia bloodstream infections in the hematologic malignancy population. Karaba SM, Goodman KE, Amoah J, Cosgrove SE, Tamma PD. Antimicrob Agents Chemother. 2021;65:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373258</ArticleId><ArticleId IdType="pubmed">34060899</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate. Alsuhaibani M, Aljarbou A, Althawadi S, Alsweed A, Al-Hajjar S. Antimicrob Resist Infect Control. 2021;10:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825200</ArticleId><ArticleId IdType="pubmed">33482916</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenotrophomonas maltophilia bacteremia in children - a 10-year analysis. Büyükcam A, Bıçakcıgil A, Cengiz AB, Sancak B, Ceyhan M, Kara A. Arch Argent Pediatr. 2020;118:0–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">32470274</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 disease and immune dysregulation. Davitt E, Davitt C, Mazer MB, Areti SS, Hotchkiss RS, Remy KE. Best Pract Res Clin Haematol. 2022;35:101401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9568269</ArticleId><ArticleId IdType="pubmed">36494149</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of dysregulated immune responses in COVID-19 pathogenesis. Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, Rafiei A. Virus Res. 2020;290:198197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561578</ArticleId><ArticleId IdType="pubmed">33069815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>